have a different understanding of the role of gelsolin in ILD and are more inclined to believe that gelsolin may maintain the inherent antimicrobial activity of the airway surface (53) and improve airway mucus viscosity by degrading a large amount of filamentous actin released by dead cells during inflammation (54). Here, GSN is linked to interstitial lung disease.